Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Kala Pharmaceuticals Inc (KALA)

Kala Pharmaceuticals Inc (KALA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kala Pharmaceuticals Inc 490 ARSENAL WAY SUITE 120 WALTHAM MA 02453 USA

P: 781-996-5252 F: 781-642-0399

Description:

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals, Inc. is based in Waltham, United States.

Key Statistics

Overview:

Market Capitalization, $K 142,829
Shares Outstanding, K 34,007
Annual Sales, $ 0 K
Annual Net Income, $ -66,740 K
Last Quarter Sales, $ 2,060 K
Last Quarter Net Income, $ -23,830 K
60-Month Beta 2.15
% of Insider Shareholders 30.77%
% of Institutional Shareholders 68.69%
Float, K 23,543
% Float 69.23%

Growth:

1-Year Return -62.80%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/06/19
Earnings Per Share ttm -2.82
EPS Growth vs. Prev Qtr 5.41%
EPS Growth vs. Prev Year -16.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

KALA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.39
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -117.68
Return-on-Assets (Before Tax) -52.43
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.86
Price/Sales 38.32
Price/Cash Flow N/A
Price/Book 2.25
Book Value/Share 1.80
Interest Coverage -19.16
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar